Abstract
The endothelial cells of capillaries within the brain constitute a barrier for the delivery of water-soluble drugs to this anatomic site. Intracarotid infusions of hyperosmotic solutions of mannitol disrupt these tight endothelial cell junctions both in normal brain and intracerebral tumors1. Neuwelt et al. have shown that osmotic blood-brain barrier (BBB) disruption can increase the uptake of both low and high molecular weight substances by brain tumors in experimental animals and humans2,3. The purpose of the present study was to determine if BBB disruption could significantly and specifically enhance the uptake of p-boronophenylalanine (BPA), which has been used as a capture agent for boron neutron capture therapy (BNCT) of intracerebral gliomas and melanomas in experimental animal studies4,5. The following report describes our studies on the effects of BBB disruption on the uptake of BPA using the F98 rat glioma, which simulates human glioblastoma multiforme in its biologic behavior.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
C.D. Fenstermacher and A.L. Cowles, Theoretic limitation of intracarotid infusion in brain tumor chemotherapy. Cancer Treat. Rep. 61: 519–526, 1977
E.A. Neuwelt, J. Howieson, and E.P. Frenkel, Therapeutic efficacy ofmultiagent chemotherapy with drug enhancement by blood-brain barrier modification in glioblastoma, Neurosurgery. 19: 573–582, 1986.
E.A. Neuwelt, H.D Specht, P.A. Barnett, S.A Dahlborg, R.N. Abbey Miley, S.M. Larson, P. Brown, K.F. Eckerman, K.E Hellström, I. Hellström. Increased delivery of tumor-specific monoclonal antibodies to brain after blood-brain barrier modification in patients with melanoma metastatic to central nervous. Neurosurgery. 20: 885–895, 1987.
K.Z Matalka, R.F. Barth, A.E. Staubus, M.L Moeschberger, J.A. Coderre. Neutron capture therapy of rat glioma using boronophenylalanine as a capture agent. Radiat. Res. 137, 44–51. 1993.
K.Z Matalka, M.Q. Bailey, R.F. Barth, A.E. Staubus, A.H. Soloway, M.L Moeschberger, J.A. Coderre, and E.K. Rofstad. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent. Cancer Res. 53: 3308–3313, 1993.
N.R Clendenon, R.F. Barth, WA. Gordon, J.H. Goodman, F. Alam, A.E. Staubus, C.P. Boesel, A.J.Yates, M.L. Moeschberger, R.G. Fairchild and J.A. Kalef-Ezra. Boron neutron capture therapy of a rat glioma. Neurosurgery. 26: 47–55, 1990.
E.A Neuwelt, N.P. Barnett, I. Hellström, K.E. Hellström, P. Beaumier, C.I. Mccormick, R.M Weigel, Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragment to normal brain utilizing osmotic blood-brain barrier disruption. Cancer Res. 48: 4725–4729, 1988.
R.F. Barth, D.M. Adams, A.H Soloway, E.B Mechetner, F. Alam, and A.K.M. Anisuzzaman. Determination of boron in tissues and cells using direct-current plasma atomic emmission spectroscopy. Anal. Chem. 63: 890–893, 1991.
A.K Kumagai, J.B Eisenberg and W.M Pardridge, Absorptive-mediated endocystosis cationized albumin and a B-endorphin-cationized almumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J. Biol. Chem. 262: 15214–15219, 1987.
W.R Shapiro, R.M Voorhies, E.M Hiesiger, P.B Sher, G.A Basler and L.E. Lipschutz, Pharmacokinetics of tumor cell exposure to [’4C] methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barrier in rat brain tumor: a quantitative autoradiographic study. Cancer Res. 48: 694–701, 1988.
T. Lahann, C. Sills, G. Hematillake, T. Dymock and G. Daniell. Cardiovascular toxicities associated with i.v. administration of p-BPA formulation. in Advances in Neutron Capture Therapy, eds. Soloway, A.H., Barth, R.F. and Carpenter, D.E., Plenum Press. New York, 1993,pp 513–517.
E.A. Neuwelt, P.A. Barnett, K.E. Hellström, I. Hellström, C.I. Mccormick, and F.L. Ramsey. Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts. J Nucl Med. 35: 1831–1841, 1994.
W. Yang, R.F. Barth, D.E. Carpenter, M.L. Mocschberger, and J.H. Goodman. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. Neurosurgery 38: 985–992, 1996.
W. Yang, R.F. Barth, J.H. Rotary, M.L. Moeschberger, D.E. Carpenter, D.D. Joel, M.M. Nawrocky, and J.H. Goodman. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood brain barrier disruption and intracarotid injection of boronophenylalanine. J. Neuro-oncol., 1997 (in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yang, W., Barth, R.F., Carpenter, D.E., Goodman, J.H. (1996). Enhanced Tumor Uptake of Boronophenylalanine by Means of Osmotic Blood-Brain Barrier Disruption in Glioma—Bearing Rats. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_78
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_78
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive